A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis

NCT00883623 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Primary Amyloidosis

Interventions

DRUG: Lenalidomide

Sponsor

Heidelberg University

Collaborators

[object Object]